Pharmaceutical Manufacturing Handbook: Production and

REFERENCES 387
16. Anal , A. K. ( 2007 ), Time - controlled pulsatile delivery systems for bioactive compounds,
Recent Patents Drug Deliv . Formulat. , 1 , 73 – 79 .
17. Chan , O. H. , and Stewart , B. H. ( 1996 ), Physico - chemical and drug delivery considerations
for oral drug bioavaibility . Drug Discovery Today , 1 , 461 – 472 .
18. Wilson , C. G. ( 2000 ), Gastrointestinal transit and drug absorption , in Oral Drug Absorption:
Prediction and Assessment , Marcel Dekker , New York , pp. 1 – 9 .
19. Knutson , L. , Knutson , F. , and Knutson , T. ( 2000 ), Permeability in the gastrointestinal
tract , in Oral Drug Absorption: Prediction and Assessment , Marcel Dekker , New York ,
pp. 11 – 16 .
20. Waterbeemd , H. V. ( 2000 ), Intestinal permeability: Prediction from theory , in Oral Drug
Absorption: Prediction and Assessment , Marcel Dekker , New York , pp. 31 – 49 .
21. Chien , Y. W. ( 1992 ), Novel Drug Delivery Systems , Vol. I, Marcel Dekker , New York ,
pp. 139 – 196 .
22. Jantzen , G. M. , and Robinson , J. R. ( 2000 ), Sustained and controlled release drug delivery
systems , in Modern Pharmaceutics , Marcel Dekker , New York , pp. 501 – 528 .
23. Welling , P. G. ( 1983 ), Oral controlled drug adminstration: Pharmacokinetic considerations
. Drug Dev. Ind. Pharm. , 9 , 1185 – 1125 .
24. Hofman , A. F. , Dressman , J. H. , Code , C. F. , and Witztum , K. F. ( 1983 ), Controlled entry
of oral administered drugs: Physiological considerations , Drug Dev. Ind. Pharm. , 9 ,
1077 – 1083 .
25. Fara , J. W. ( 1983 ), Gastrointestinal transit of solid dosage forms . Pharm. Technol. , 7 ,
23 – 26 .
26. Meyer , J. H. , Ohashi , H. , Jehn , D. , and Thomson , J. B. ( 1981 ), Size of particles emptied
from the human stomach , Gastroenterology , 80 , 1489 – 1496 .
27. Welling , P. G. , and Dobrinska , M. R. ( 1987 ), Dosing considerations and bioavailability
assessment of controlled drug delivery systems , in Controlled Drug Delivery: Fundamentals
and Applications , Marcel Dekker , New York , pp. 253 – 289 .
28. Hinton , J. M. , Lennard - Jones , J. E. , and Young , A. C. ( 1969 ), Alimentary canal transit
time for an inert object in humans , Gut , 10 , 842 .
29. Frier , M. , and Perkins , A. C. ( 1994 ), Radiopharmaceuticals and the gastrointestinal tract ,
Eur. J. Nucl. Med. Mol. Imaging , 21 , 1234 – 1242 .
30. Basit , A. W. , Podczeck , F. , Newton , M. , Waddington , W. A. , Ell , P. J. , and Lacey , L. F.
( 2004 ), The use of formulation technology to assess regional gastrointestinal drug
absorption in humans , Eur. J. Pharm. Sci. , 21 , 179 – 189 .
31. Delie , F. , and Blanco - Pr í eto , M. J. ( 2005 ), Polymeric particulares to improve oral bioavailability
of peptide drugs , Molecules , 10 , 65 – 80 .
32. Walter , E. , Kissel , T. , and Amidon , G. E. ( 1996 ), The intestinal peptide carrier: A potential
transport system for small peptide - derived drugs , Adv Drug Deliv. Rev. , 20 , 33 – 58 .
33. Scheline , R. R. ( 1973 ), Metabolism of foreign compounds by gastrointestinal microorganisms
, Pharmacol. Rev. , 25 , 451 – 523 .
34. Edwards , C. ( 1997 ), Physiology of colorectal barrier . Adv. Drug Deliv. Rev. , 28 , 173 – 190 .
35. Whateley , T. L. ( 1992 ), Microencapsulation of Drugs , Harwood Academic , Geneva,
Switzerland .
36. Anal , A. K. , and Stevens , W. F. ( 2005 ), Chitosan - alginate multilayer beads for controlled
release of ampicillin , Int. J. Pharm. , 290 , 45 – 54 .
37. Anal , A. K. , Bhopatkar , D. , Tokura , S. , Tamura , H. , and Stevens , W. F. ( 2003 ), Chitosan -
alginate multilayer beads for gastric passage and controlled intestinal release of protein ,
Drug Dev. Ind. Pharm. , 29 , 713 – 724 .